High rate of positive circumferential resection margins following rectal cancer surgery a call to action

Annals of Surgery

Volumn 262, Issue 6, 2015, Pages 891-898

  Rickles, Aaron S ^a   Dietz, David W ^b   Chang, George J ^c   Wexner, Steven D ^d   Berho, Mariana E ^d   Remzi, Feza H ^b   Greene, Frederick L ^e   Fleshman, James W ^f   Abbas, Maher A ^g   Peters, Walter ^h   Noyes, Katia ^a   Monson, John R T ^a   Fleming, Fergal J ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d DEPARTMENT OF COLORECTAL SURGERY   (United States)

^e LEVINE CANCER INSTITUTE   (United States)

^f BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^g HEART AND VASCULAR INSTITUTE   (United Arab Emirates)

^h Department of Surgery   (United States)

Author keywords

Centers of excellence; Circumferential resection margin; Rectal cancer; Rectal cancer outcomes; Total mesorectal excision

Indexed keywords

ADULT; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBIDITY; OPERATION DURATION; POSITIVE CIRCUMFERENTIAL RESECTION MARGIN; PRIORITY JOURNAL; RECTUM CANCER; RECTUM RESECTION; RECURRENCE RISK; SURGICAL APPROACH; TUMOR INVASION; TUMOR VOLUME; UNITED STATES; ABDOMINAL SURGERY; ADENOCARCINOMA; AGED; FACTUAL DATABASE; MULTIVARIATE ANALYSIS; PATHOLOGY; RECTAL NEOPLASMS; RECTUM; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; DATABASES, FACTUAL; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; RECTAL NEOPLASMS; RECTUM; RISK FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84948710410     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000001391     Document Type: Article

References (33)

1. Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery: the clue to pelvic recurrence? Br J Surg. 1982;69:613-616.
2. Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986;1:1479-1482.
3. MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet. 1993;341:457-460.
4. Peeters KC, Marijnen CA, Nagtegaal ID, et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg. 2007;246:693-701.
5. Martling AL, Holm T, Rutqvist LE, et al. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet. 2000;356:93-96.
6. Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009;373:811-820.
7. Quirke P, Durdey P, Dixon MF, et al. Local recurrence of rectal adenocarci-noma due to inadequate surgical resection: histopathological study of lateral tumour spread and surgical excision. Lancet. 1986;2:996-999.
8. Nagtegaal ID, Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol. 2008;26:303-312.
9. Dietz DW. Consortium for Optimizing Surgical Treatment of Rectal C. Multidisciplinary management of rectal cancer: the OSTRICH. J Gastrointest Surg. 2013;17:1863-1868.
10. Archampong D, Borowski D, Wille-Jorgensen P, et al. Workload and surgeon's specialty for outcome after colorectal cancer surgery. Cochrane Database Syst Rev. 2012;3:CD005391.
11. Kreiter E, Yasui Y, de Gara C, et al. Referral rate to oncologists and its variation by hospital for colorectal cancer patients. Ann Surg Oncol. 2012;19:714-721.
12. Wexner SD, Rotholtz NA. Surgeon influenced variables in resectional rectal cancer surgery. Dis Colon Rectum. 2000;43:1606-1627.
13. Monson JR, Probst CP, Wexner SD, et al. Failure of evidence-based cancer care in the United States: the association between rectal cancer treatment, cancer center volume, and geography. Ann Surg. 2014;260:625-632.
14. Delivering High-Quality Cancer Care: Charting a New Course For a System in Crisis. Brief Report, Institute of Medicine, September 2013.
15. Wibe A, Moller B, Norstein J, et al. A national strategic change in treatment policy for rectal cancer-implementation of total mesorectal excision as routine treatment in Norway: a national audit. Dis Colon Rectum. 2002;45:857-866.
16. Dahlberg M, Glimelius B, Pahlman L. Changing strategy for rectal cancer is associated with improved outcome. Br J Surg. 1999;86:379-384.
17. Khani MH, Smedh K. Centralization of rectal cancer surgery improves long-term survival. Colorectal Dis. 2010;12:874-879.
18. Tekkis PP, Heriot AG, Smith J, et al. Comparison of circumferential margin involvement between restorative and nonrestorative resections for rectal cancer. Colorectal Dis. 2005;7:369-374.
19. Rullier A, Gourgou-Bourgade S, Jarlier M, et al. Predictive factors of positive circumferential resection margin after radiochemotherapy for rectal cancer: the French randomised trial ACCORD12(0405 PRODIGE 2. Eur J Cancer. 2013;49:82-89.
20. Bilimoria KY, Stewart AK, Winchester DP, et al. The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol. 2008;15:683-690.
21. Deyo RA, Cherkin DC, Ciol MA. Adaptinga clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-619.
22. Russell MC, You YN, Hu CY, et al. A novel risk-adjusted nomogram for rectal cancer surgery outcomes. JAMA Surg. 2013;148:769-777.
23. Massarweh NN, Hu CY, You YN, et al. Risk-adjusted pathologic margin positivity rate as a quality indicator in rectal cancer surgery. J Clin Oncol. 2014;32:2967-2974.
24. Washington K, Tang LH, Berlin J, et al. Protocol for the Examination of Specimens from Patients with Primary Carcinoma of the Colon and Rectum. Arch Pathol Lab Med. 2010;134(2):176-180.
25. Wibe A, Syse A, Andersen E, et al. Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection. Dis Colon Rectum. 2004;47:48-58.
26. Phang PT, McGahan CE, McGregor G, et al. Effects of change in rectal cancer management on outcomes in British Columbia. Can J Surg. 2010;53: 225-231.
27. Oberholzer K, Menig M, Kreft A, et al. Rectal cancer: mucinous carcinoma on magnetic resonance imaging indicates poor response to neoadjuvant chemo-radiation. Int J Radiat Oncol Biol Phys. 2012;82:842-848.
28. Hiranyakas A, da Silva G, Wexner SD, et al. Factors influencing circumferential resection margin in rectal cancer. Colorectal Dis. 2013;15: 298-303.
29. Taylor FG, Quirke P, Heald RJ, et al. Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study. J Clin Oncol. 2014;32:34-43.
30. Quirke P, Steele R, Monson J, et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet. 2009;373:821-828.
31. Maslekar S, Sharma A, Macdonald A, et al. Mesorectal grades predict recurrences after curative resection for rectal cancer. Dis Colon Rectum. 2007;50:168-175.
32. Strassburg J, Ruppert R, Ptok H, et al. MRI-based indications for neoadjuvant radiochemotherapy in rectal carcinoma: interim results of a prospective multicenter observational study. Ann Surg Oncol. 2011;18:2790-2799.
33. Phang PT. Evolving rectal cancer management in British Columbia. Can J Surg. 2010;53:222-224.